Food and Drugs Administration, Haryana, India. |
Email ID: fdazone@gmail.com
- Important short notes for Industry and Regulators - November 3, 2024
- Remifentanil: A Powerful Pain Medication - June 29, 2024
- Requirements for License for Repacking of Drugs: Key points - May 24, 2024
Last Updated on July 11, 2024 by The Health Master
Remifentanil
Remifentanil is a potent, synthetic opioid analgesic used during surgery to provide pain relief.
It is typically administered through injection and works by binding to opioid receptors in the central nervous system (CNS).
Legal Classification
Remifentanil is classified as a manufactured drug under the Narcotic And Psychotropic Drugs Act 1985 (NDPS Act), specifically Section 2(b)(xi) vide notification No. S.O.1431(E) dated 21 June 2011.
This means it is a controlled substance with restrictions on its use and distribution.
Availability and Recent Designation
Remifentanil is available in injectable forms of 1mg and 2mg.
It was designated as a new drug by the Drugs Controller General (I) (DCGI), CDSCO in 2024.
However, it is not yet classified as an Essential Narcotic Drug (END) under Rule 52 N of the NDPS Act.
Important Note
Remifentanil is a powerful medication that should only be used under the supervision of a licensed medical professional.
It has the potential for serious side effects, including respiratory depression.
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
